neweimear
Senior Member
- Messages
- 215
Hi
Not in the best of spirits here and thinking has much happened since Jan 2017 in terms of ME research progress. I'm not feeling too excited. I must admit I was so thrilled with OMF's findings early in the year, Mark Davis also perked me up. The increase in NIH funding another plus and the three Research Centres. The Norwegians gone to phase B of CycloME trial. The researcher Systrum on the cardiac pulmonary system and Naviaux. Suramin....too far away but still, a drug mentioned. Also, good to hear Dr. Davis mention clinical trials but not sure what they are targeting if they don't know what the substance in the blood is that causes cells to stress. Oh yes, the intramural study. Great its happening but way too slow. Any other positives or hopeful thoughts on 2017. I know rituximab also but I'm not overly hopeful on that due to so many unsuccessful treatments people have had on here. And of course Unrest but will Unrest increase NIH funding???
Not in the best of spirits here and thinking has much happened since Jan 2017 in terms of ME research progress. I'm not feeling too excited. I must admit I was so thrilled with OMF's findings early in the year, Mark Davis also perked me up. The increase in NIH funding another plus and the three Research Centres. The Norwegians gone to phase B of CycloME trial. The researcher Systrum on the cardiac pulmonary system and Naviaux. Suramin....too far away but still, a drug mentioned. Also, good to hear Dr. Davis mention clinical trials but not sure what they are targeting if they don't know what the substance in the blood is that causes cells to stress. Oh yes, the intramural study. Great its happening but way too slow. Any other positives or hopeful thoughts on 2017. I know rituximab also but I'm not overly hopeful on that due to so many unsuccessful treatments people have had on here. And of course Unrest but will Unrest increase NIH funding???
Last edited: